首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Second primary in the contralateral breast after treatment of breast cancer.
【24h】

Second primary in the contralateral breast after treatment of breast cancer.

机译:第二原发于对侧乳腺癌治疗后。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To study the potential risk factors for contralateral breast cancer (CBC) in women after treatment of the primary breast cancer. PATIENTS AND METHODS: Between January 1985 and December 1995, records of 1084 breast cancer patients at our institution were analyzed for incidence of CBC. In all the patients a detailed analysis was carried out with respect to age, disease stage, radiation therapy technique, dose, the use of chemotherapy or hormone therapy, and other clinical and/or pathologic characteristics. The Kaplan-Meier method was used to estimate the acturial rate of CBC. The Cox proportional hazard regression model was used to estimate the relative risk (RR) of CBC. RESULTS: Up to December 2005, the median follow up was 12 years. Overall incidence of CBC was 4%. The 10 and 20 year acturial rate of CBC was 5.6% and 11.3%, respectively. The CBC rate at 10 and 20 year was 5.4% and 10.2%, respectively, for patients with mastectomy only and 5.1% and 9.7%, respectively, in the mastectomy plus RT group (p=0.3). In the subset of patients <45 years of age at the time of treatment, 10 and 20 year acturial rate of CBC was 5% and 9%, respectively, for patients who underwent mastectomy only and 6.3% and 11%, respectively, for patients treated with mastectomy plus RT (RR=1.4, 95% CI: 1.14-1.45, p=0.003). There was statistically significant lower rate of CBC in patients given adjuvant hormonal therapy (8.5%) as compared to those without hormonal therapy (14.3%, p=0.004) at 20 year. Women with family history of breast cancer had highest rate (15.3%) of CBC (RR=1.6, 95% CI: 1.12-1.27) at 20 years. The adjuvant use of chemotherapy did not significantly affect the risk of second malignancy. CONCLUSION: There seems to be little risk of second malignancies in patients treated with mastectomy plus RT using modern techniques, compared with mastectomy only, that was only prevalent in patients <45 years of age. Family history of breast cancer seems to be the highest risk factor for CBC.
机译:目的:研究原发性乳腺癌治疗后女性对侧乳腺癌(CBC)的潜在危险因素。患者与方法:从1985年1月至1995年12月,分析了我院1084例乳腺癌患者的CBC发病率。在所有患者中,对年龄,疾病分期,放射治疗技术,剂量,化学疗法或激素治疗的使用以及其他临床和/或病理特征进行了详细分析。用Kaplan-Meier方法估计CBC的尿道白细胞率。使用Cox比例风险回归模型估计CBC的相对风险(RR)。结果:截至2005年12月,中位随访时间为12年。 CBC的总发生率为4%。 CBC的10年和20年尿道造血率分别为5.6%和11.3%。仅乳腺切除术的患者在10年和20年时的CBC率分别为5.4%和10.2%,而乳腺切除术加RT组的CBC率分别为5.1%和9.7%(p = 0.3)。在接受治疗的年龄小于45岁的患者子集中,仅接受乳房切除术的患者的10年和20年的CBC尿uri病率分别为5%和9%,分别为6.3%和11%乳房切除术加放疗治疗(RR = 1.4,95%CI:1.14-1.45,p = 0.003)。在20年时,接受激素辅助治疗的患者(8.5%)的CBC率与未接受激素治疗的患者(14.3%,p = 0.004)相比在统计学上显着降低。有乳腺癌家族史的女性在20年时的CBC率最高(15.3%)(RR = 1.6,95%CI:1.12-1.27)。化疗的辅助使用并未显着影响继发恶性肿瘤的风险。结论:与仅使用乳房切除术相比,使用现代技术行乳房切除术加RT治疗的患者发生第二次恶性肿瘤的风险似乎很小,仅在<45岁的患者中普遍存在。乳腺癌的家族史似乎是CBC的最高危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号